Bringing the future into focus


Key publications 2013

Boon CFJ, van de Ven JPH, Hoyng CB, den Hollander AI, Klevering BJ. Cuticular drusen: stars in the sky. Prog Retin Eye Res 2013; 37:90-113. Pubmed

Droege KM, Muether PS, Hermann MM, Caramoy A, Viebahn U, Kirchhof B, Fauser S. Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life. Graefes Arch Clin Exp Ophthalmol 2013; 251(5):1281-1284. Pubmed

Helgason H, Sulem P, Duvvari MR, Luo H, Thorleifsson G, Stefansson H, Jonsdottir I, Masson G, Gudbjartsson DF, Walters GB, Magnusson OT, Kong A, Rafnar T, Kiemeney LA, Schoenmaker-Koller FE, Zhao L, Boon CJF, Song Y, Fauser S, Pei M, Ristau T, Patel S, Liakopoulos S, van de Ven JPH, Hoyng CB, Ferreyra H, Duan Y, Bernstein PS, Geirsdottir A, Helgadottir G, Stefansson E, den Hollander AI, Zhang K, Jonasson F, Sigurdsson H, Thorsteinsdottir U, Stefansson K. A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration. Nature Genet 2013; 45(11):1371-1374. Pubmed

Hoerster R, Muether P, Dahlke C, Mehler K, Oberthür A, Kirchof B, Fauser S. Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurity. Acta Ophthalmol 2013; 91(1):e74-75. Pubmed

Muether PS, Hermann MM, Dröge K, Kirchof B, Fauser S. Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration. Am J Ophthalmol 2013; 156(5):989-993. Pubmed

Muether PS, Hoerster R, Hermann MM, Kirchof B, Fauser S. Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2013; 251(2):453-458. Pubmed

Muether PS, Neuhann I, Buhl C, Hermann MM, Kirchof B, Fauser S. Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration. Retina 2013; 33(9):1809-1814. Pubmed

Silva R, Axer-Siegel R, Eldem B, Guymer R, Kirchof B, Papp A, Seres A, Gekkieva M, Nieweg A, Pilz S; SECURE Study Group. The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degeneration. Ophthalmology 2013; 120(1):130-139. Pubmed

van de Ven JPH, Nilsson SC, Tan PL, Buitendijk GHS, Ristau T, Mohlin FC, Nabuurs SB, Schoenmaker-Koller FE, Smailhodzic D, Campochiarro PA, Zack DJ, Duvvari MR, Bakker B, Paun CC, Boon CJF, Uitterlinden AG, Liakopoulos S, Klevering BJ, Fauser S, Daha MR, Katsanis N, Klaver CCW, Blom AM, Hoyng CB, den Hollander AI. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet 2013; 45(7):813-817. Pubmed

van Grinsven MJ, Lechanteur YT, van de Ven JP, van Ginneken B, Hoyng CB, Theelen T, Sánchez CI. Automatic drusen quantification and risk assessment of age-related macular degeneration on color fundus images. Invest Ophthalmol Vis Sci 2013; 54(4):3019-3027. Pubmed